**Core Concept:** Steroid-dependent nephrotic syndrome is a severe form of nephrotic syndrome where the patient requires corticosteroids to maintain remission. Steroid toxicity occurs when prolonged corticosteroid therapy causes adverse effects, including cataract formation. Alternative treatments are needed to manage the disease while minimizing corticosteroid exposure.

**Why the Correct Answer is Right:** Corticosteroid-sparing agents are medications used to reduce corticosteroid dependency in nephrotic syndrome patients. Calcineurin inhibitors (CNIs), such as cyclosporine and tacrolimus, are effective immunosuppressive agents used for this purpose. They inhibit the production of cytokines, reducing proteinuria and preserving renal function.

**Why Each Wrong Option is Incorrect:**

A. Hydrocortisone (steroid) - This is incorrect because it would not address the steroid dependency and increase corticosteroid exposure.
B. Cyclophosphamide - While cyclophosphamide is an immunosuppressive agent, it is not specifically designed for corticosteroid-sparing effects in nephrotic syndrome.
C. Mycophenolate mofetil - This is incorrect because it is a purine analogue with less corticosteroid-sparing properties compared to CNIs.
D. Azathioprine - Azathioprine is an immunosuppressive agent; however, its corticosteroid-sparing effects are inferior to CNIs.

**Clinical Pearl:** CNIs are the preferred corticosteroid-sparing agents in steroid-dependent nephrotic syndrome due to their superior corticosteroid-sparing effects, preserving renal function, and reducing proteinuria. Mycophenolate mofetil and azathioprine are not as effective as CNIs in this regard.

**Correct Answer:** D. Cyclosporine (C) is the best alternative for the treatment of steroid-dependent nephrotic syndrome, as it has potent corticosteroid-sparing effects and is more effective in preserving renal function and reducing proteinuria compared to other options.